Search NLS News

The first test results from patient 1 have been received and show a very strong effect on the marker of osteoclast activity (CTX), states the company. The baseline value for CTX decreases by about 80% after 3 doses of OsteoDex. The other values are fairly constant (cf. baseline). Osteoclasts break down bone (resorb) and CTX […]

Swedish pre-clinical biomarker assay company Offspring Biosciences and US spatial biology and biomarker analytics company Flagship Biosciences have announced a strategic partnership. The partnership aims to further advance precision drug development with a complete biomarker offering from discovery to companion diagnostics development, the companies state. “Together, Flagship Biosciences and Offspring Biosciences will provide a seamless […]

Norwegian biotech company Arxx Therapeutics will merge with Dutch pharma company Oxitope Pharma to create Calluna Pharma Inc. The merger followed a completed Series A round of EUR 75 million, led by the European investor Forbion, and included existing Arxx investors Sarsia, p53 and Investinor. The funding will last until late 2026, and will support […]

The board of WntResearch has appointed Per Norlén as the company’s new CEO. Per Norlén has solid experience from the life science industry in general and the development of cancer drugs in particular, states WntResearch. I would also like to take this opportunity to thank Pernilla Sandwall, who has now decided to move on, for […]

The Board of Directors of Xbrane Biopharma has announced a rights issue of units of approximately SEK 343 million, consisting of shares and warrants of series TO1. Upon full exercise of the warrants of series TO1, Xbrane will receive approximately up to an additional SEK 78 million. The Rights Issue is conditional upon approval by […]

The board of directors of Medivir has resolved on a directed issue through which the company receives approximately SEK 20 million before issue costs. The right to subscribe for shares in the Directed Issue shall, with deviation from the shareholders pre-emption rights, belong to Hallberg Management AB (HMAB). HMAB is controlled by Anders Hallberg, former […]

The United States Patent and Trademark Office (USPTO) has issued US Patent covering ATOR-4066, a Neo-X-Prime next generation bispecific antibody targeting CD40 and CEACAM5, in the treatment of cancer. The patent, titled ”Novel peptides”, provides ATOR-4066 with protection regarding methods of treating cancer and/or a tumor using a bispecific antibody comprising the complementarity-determining regions (CDRs) […]

Nordic life science companies are generally of good quality, but can often be better at pitching compared to US-based companies and entrepreneurs. Effective pitching is a skill, and is centered on good storytelling to get an investor’s full attention and buy-in. Since I work for the life science VC, HealthCap, I thought I would share […]

Tomas Blomquist will leave his role as CEO and President of the company with immediate effect. The Chairman of the Board, Torben Jørgensen, has been appointed by the Board of Directors as interim CEO while the process of recruiting a new CEO is finalized. “The Board wishes to thank Tomas Blomquist for the four years […]

With the acquisition GBA Group is expanding its range of consulting and training services for the medical device, In Vitro Diagnostics (IVD), and pharmaceutical industry. “As we have set ourselves the goal of being a broad-based service provider for medical devices, Key2Compliance, with its consulting and training services and expertise, is a perfect fit for […]